Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
Stefania De Lorenzo(Azienda USL di Bologna), Giovanni Brandi(Hôpital Beaujon), Karim Boudjéma(Inserm), Alessandro Granito(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Heithem Jeddou(Institut de Recherche en Informatique et Systèmes Aléatoires), Deborah Malvi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Thomas Uguen(Hôpital Pontchaillou), Bruno Turlin(Inserm), Francesco Vasuri(Ospedale "Santa Maria delle Croci" di Ravenna), Julien Edeline(Inserm), Astrid Lièvre(Inserm), Alessandro Mazzotta(Inserm), Matteo Renzulli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Antonietta D’Errico, Francesco Tovoli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 56
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
|Journal of Biological Chemistry|2001|1.7k